BDNF and Alzheimer disease: Biochemically, compound (IV) was capable of mitigating AlCl3-induced neurotoxicity and AD-like pathology through exerting anti-inflammatory activities via reducing IL-6 levels, and anti-oxidative activities via restoring TAC levels, and demonstrated a restoring potential of synaptic dysfunction via increasing BDNF levels.